213 related articles for article (PubMed ID: 28018172)
1. APP Causes Hyperexcitability in Fragile X Mice.
Westmark CJ; Chuang SC; Hays SA; Filon MJ; Ray BC; Westmark PR; Gibson JR; Huber KM; Wong RK
Front Mol Neurosci; 2016; 9():147. PubMed ID: 28018172
[TBL] [Abstract][Full Text] [Related]
2. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
[TBL] [Abstract][Full Text] [Related]
3. Hyperexcitability in the olfactory bulb and impaired fine odor discrimination in the
Kuruppath P; Xue L; Pouille F; Jones ST; Schoppa NE
bioRxiv; 2023 Apr; ():. PubMed ID: 37090519
[TBL] [Abstract][Full Text] [Related]
4. Effects of the presence and absence of amino acids on translation, signaling, and long-term depression in hippocampal slices from Fmr1 knockout mice.
Cooke SK; Russin J; Moulton K; Nadel J; Loutaev I; Gu Q; Li Z; Smith CB
J Neurochem; 2019 Dec; 151(6):764-776. PubMed ID: 31539452
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
6. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
[TBL] [Abstract][Full Text] [Related]
7. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
8. Fragile X and APP: a Decade in Review, a Vision for the Future.
Westmark CJ
Mol Neurobiol; 2019 Jun; 56(6):3904-3921. PubMed ID: 30225775
[TBL] [Abstract][Full Text] [Related]
9. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
Zhang L; Alger BE
J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
[TBL] [Abstract][Full Text] [Related]
10. GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome.
Wahlstrom-Helgren S; Klyachko VA
J Physiol; 2015 Nov; 593(22):5009-24. PubMed ID: 26282581
[TBL] [Abstract][Full Text] [Related]
11. Decreased surface expression of the δ subunit of the GABA
Zhang N; Peng Z; Tong X; Lindemeyer AK; Cetina Y; Huang CS; Olsen RW; Otis TS; Houser CR
Exp Neurol; 2017 Nov; 297():168-178. PubMed ID: 28822839
[TBL] [Abstract][Full Text] [Related]
12. Comparative Behavioral Phenotypes of
Saré RM; Figueroa C; Lemons A; Loutaev I; Beebe Smith C
Brain Sci; 2019 Jan; 9(1):. PubMed ID: 30654445
[TBL] [Abstract][Full Text] [Related]
13. ER stress-induced modulation of neural activity and seizure susceptibility is impaired in a fragile X syndrome mouse model.
Liu DC; Lee KY; Lizarazo S; Cook JK; Tsai NP
Neurobiol Dis; 2021 Oct; 158():105450. PubMed ID: 34303799
[TBL] [Abstract][Full Text] [Related]
14. Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.
Schaefer TL; Davenport MH; Grainger LM; Robinson CK; Earnheart AT; Stegman MS; Lang AL; Ashworth AA; Molinaro G; Huber KM; Erickson CA
J Neurodev Disord; 2017; 9():6. PubMed ID: 28616095
[TBL] [Abstract][Full Text] [Related]
15. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
[TBL] [Abstract][Full Text] [Related]
16. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
[TBL] [Abstract][Full Text] [Related]
17. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
19. Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice.
Westmark CJ; Westmark PR; O'Riordan KJ; Ray BC; Hervey CM; Salamat MS; Abozeid SH; Stein KM; Stodola LA; Tranfaglia M; Burger C; Berry-Kravis EM; Malter JS
PLoS One; 2011; 6(10):e26549. PubMed ID: 22046307
[TBL] [Abstract][Full Text] [Related]
20. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
